メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界における再生医療の市場

Regenerative Medicine Market

発行 Progressive Markets Research 商品コード 649309
出版日 ページ情報 英文 165 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.76円で換算しております。
Back to Top
世界における再生医療の市場 Regenerative Medicine Market
出版日: 2018年04月01日 ページ情報: 英文 165 Pages
概要

当レポートでは、世界の再生医療市場について調査し、市場の現状と成長予測、タイプ別、材料別、用途別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 市況

  • 成長促進因子
  • 阻害因子と課題
  • ポーターズ分析
  • 市場シェア分析

第4章 タイプ別市場

  • 組織エンジニアリング
  • 細胞治療
  • 小分子・生物製剤
  • 遺伝子治療

第5章 材料別市場

  • 合成材料
  • 遺伝子組み換え材料
  • 医薬品
  • 生物由来材料

第6章 用途別市場

  • 心血管
  • 眼科
  • 皮膚科
  • 筋骨格
  • 創傷治療
  • 腫瘍科
  • 神経科
  • その他

第7章 地域別市場

  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ

第8章 企業プロファイル

  • Zimmer biomet holdings, inc.
  • Medtronic plc
  • Stryker corporation
  • Ocata therapeutics, inc.
  • Baxter international, inc.
  • Depuy synthes
  • Organogenesis, inc.
  • Integra lifesciences holdings corporation
  • Acelity holdings, inc.
  • Cryolife, inc.
目次
Product Code: PMR1230

REGENERATIVE MEDICINE MARKET - OVERALL INDUSTRY ANALYSIS

The global regenerative medicine market was valued at $6677.7 million in 2017 and is expected to reach $64919.7 million by 2025, registering a CAGR of 33.05% during 2018-2025. Regenerative medicine is a new and fast developing field of medicine. It holds the promise of regenerating or restoring the organs and tissues in the body which are lost due to age, disease, damage, or birth abnormalities. The technique involves the use of stem cells to treat diseases or injuries using cell therapies or transplantation methods. Regenerative medicine also allows scientists to grow tissues and organs in the laboratory and implant them securely in the affected area in the body. This procedure is performed when the body cannot heal itself. This branch of medicine finds application in numerous fields including dermatology, cardiovascular diseases, osteoporosis, oncology, neurology, severe burns, spinal cord injury, congenital abnormalities, and others.

MARKET DRIVERS AND RESTRAINTS

The report the drivers and restraints impacting the growth of the regenerative market. Factors such as the rapid advancement of technology for the restorations of organs and tissues, the growing prevalence of chronic diseases worldwide, the increase in the government and private funding for the development of regenerative diseases, and the growth in geriatric population are causing the industry to grow fast. Whereas, the high cost of regenerative medicines and stringent government regulations impede the growth of the regenerative medicine market.

MARKET SEGMENTATION

Regenerative Medicine Market By Type

  • Tissue Engineering
  • Cell Therapy
  • Small Molecules & Biologics
  • Gene Therapy

Regenerative Medicine Market By Material

  • Synthetic Materials
  • Biologically derived Materials
  • Genetically Engineered Materials
  • Small Molecules and Biologics

Regenerative Medicine Market By Application

  • Cardiovascular
  • Ophthalmology
  • Dermatology
  • Musculoskeletal
  • Wound Healing
  • Oncology
  • Neurology
  • Others

Regenerative Medicine Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

KEY MARKET PLAYERS

The report offers details about the prominent players providing solution in the regenerative medicine market. The details include information about their products and specifications, the marketing strategies adopted by them to sustain in the field, their market size and share, and more. The key players mentioned in the research study include Zimmer Biomet Holdings, Inc., Medtronic plc, Stryker Corporation, Ocata Therapeutics, Inc., Baxter International, Inc., DePuy Synthes, Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., and CryoLife, Inc.

KEY TAKEAWAYS FROM THE REGENERATIVE MEDICINE MARKET REPORT

  • The report is a detailed study of the regenerative medicine market, encompassing the market size, market share analysis, market status and forecast analysis, development environmental analysis, market segmentation, market comparison analysis, market trends, and company profiles.
  • The report includes the current market trends and estimations for the period of 2018-2025 to identify the prevailing market opportunities in the different parts of the world.
  • The study includes the top investment pockets to assist stakeholders in identifying the cash cows of the industry.
  • An elaborate study of the factors that drive and restrain the growth of the regenerative medicine market is provided in the report.
  • Key manufacturers of regenerative medicine industry are profiled in the report along with the recent developments to help understand the competitive landscape of the market.
  • Comprehensive analysis of the industry assists in analyzing the growth strategies adopted by the leading market players over the past few years.

Table of Contents

1. Executive summary

  • 1.1. Key findings
  • 1.2. Market attractiveness and trend analysis
  • 1.3. Competitive landscape and recent industry development analysis

2. Introduction

  • 2.1. Report description
  • 2.2. Scope and definitions
  • 2.3. Research methodology

3. Market landscape

  • 3.1. Growth drivers
    • 3.1.1. Impact analysis
  • 3.2. Restrains and challenges
    • 3.2.1. Impact analysis
  • 3.3. Porter's analysis
    • 3.3.1. Bargaining power of buyers
    • 3.3.2. Bargaining power of suppliers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Industry rivalry
    • 3.3.5. Threat of new entrants
  • 3.4. Global regenerative medicines market shares analysis, 2014-2025
    • 3.4.1. Global regenerative medicines market share by type, 2014-2025
    • 3.4.2. Global regenerative medicines market share by material type, 2014-2025
    • 3.4.3. Global regenerative medicines market share by application type, 2014-2025
    • 3.4.4. Global regenerative medicines market share by geography, 2014-2025

4. Global regenerative medicines market by type

  • 4.1. Tissue engineering
    • 4.1.1. Historical market size by region, 2014-2016
    • 4.1.2. Market forecast by region, 2017-2025
  • 4.2. Cell therapy
    • 4.2.1. Historical market size by region, 2014-2016
    • 4.2.2. Market forecast by region, 2017-2025
  • 4.3. Small molecules & biologics
    • 4.3.1. Historical market size by region, 2014-2016
    • 4.3.2. Market forecast by region, 2017-2025
  • 4.4. Gene therapy
    • 4.4.1. Historical market size by region, 2014-2016
    • 4.4.2. Market forecast by region, 2017-2025

5. Global regenerative medicines market by material

  • 5.1. Synthetic materials
    • 5.1.1. Historical market size by region, 2014-2016
    • 5.1.2. Market forecast by region, 2017-2025
    • 5.1.3. Biodegradable synthetic polymers
      • 5.1.3.1. Historical market size by region, 2014-2016
      • 5.1.3.2. Market forecast by region, 2017-2025
    • 5.1.4. Hydrogel material
      • 5.1.4.1. Historical market size by region, 2014-2016
      • 5.1.4.2. Market forecast by region, 2017-2025
    • 5.1.5. Scaffold
      • 5.1.5.1. Historical market size by region, 2014-2016
      • 5.1.5.2. Market forecast by region, 2017-2025
    • 5.1.6. Artificial vascular graft materials
      • 5.1.6.1. Historical market size by region, 2014-2016
      • 5.1.6.2. Market forecast by region, 2017-2025
  • 5.2. Genetically engineered materials

5.2.1 Historical market size by region, 2014-2016

5.2.2 Market forecast by region, 2017-2025

5.2.3 Deoxyribonucleic acid transfection vectors

      • 5.2.3.1. Historical market size by region, 2014-2016
      • 5.2.3.2. Market forecast by region, 2017-2025

5.2.4 Genetically manipulated cells

5.2.4.1 Historical market size by region, 2014-2016

5.2.4.2 Market forecast by region, 2017-2025

    • 5.2.5. Three-dimensional polymer technology
      • 5.2.5.1. Historical market size by region, 2014-2016
      • 5.2.5.2. Market forecast by region, 2017-2025
    • 5.2.6. Transgenic
      • 5.2.6.1. Historical market size by region, 2014-2016
      • 5.2.6.2. Market forecast by region, 2017-2025
    • 5.2.7. Fibroblasts
      • 5.2.7.1. Historical market size by region, 2014-2016
      • 5.2.7.2. Market forecast by region, 2017-2025
    • 5.2.8. Neural stem cells
      • 5.2.8.1. Historical market size by region, 2014-2016
      • 5.2.8.2. Market forecast by region, 2017-2025
    • 5.2.9. Gene-activated matrices
      • 5.2.9.1. Historical market size by region, 2014-2016
      • 5.2.9.2. Market forecast by region, 2017-2025
  • 5.3. Pharmaceuticals
    • 5.3.1. Historical market size by region, 2014-2016
    • 5.3.2. Market forecast by region, 2017-2025
    • 5.3.3. Small molecules
      • 5.3.3.1. Historical market size by region, 2014-2016
      • 5.3.3.2. Market forecast by region, 2017-2025
    • 5.3.4. Biologics
      • 5.3.4.1. Historical market size by region, 2014-2016
      • 5.3.4.2. Market forecast by region, 2017-2025
  • 5.4. Biologically derived materials
    • 5.4.1. Historical market size by region, 2014-2016
    • 5.4.2. Market forecast by region, 2017-2025
    • 5.4.3. Collagen
      • 5.4.3.1. Historical market size by region, 2014-2016
      • 5.4.3.2. Market forecast by region, 2017-2025
    • 5.4.4. Xenogeneic material
      • 5.4.4.1. Historical market size by region, 2014-2016
      • 5.4.4.2. Market forecast by region, 2017-2025

6. Global regenerative medicines market by application

  • 6.1. Cardiovascular
    • 6.1.1. Historical market size by region, 2014-2016
    • 6.1.2. Market forecast by region, 2017-2025
  • 6.2. Ophthalmology
    • 6.2.1. Historical market size by region, 2014-2016
    • 6.2.2. Market forecast by region, 2017-2025
  • 6.3. Dermatology
    • 6.3.1. Historical market size by region, 2014-2016
    • 6.3.2. Market forecast by region, 2017-2025
  • 6.4. Musculoskeletal
    • 6.4.1. Historical market size by region, 2014-2016
    • 6.4.2. Market forecast by region, 2017-2025
  • 6.5. Wound healing
    • 6.5.1. Historical market size by region, 2014-2016
    • 6.5.2. Market forecast by region, 2017-2025
  • 6.6. Oncology
    • 6.6.1. Historical market size by region, 2014-2016
    • 6.6.2. Market forecast by region, 2017-2025
  • 6.7. Neurology
    • 6.7.1. Historical market size by region, 2014-2016
    • 6.7.2. Market forecast by region, 2017-2025
  • 6.8. Others
    • 6.8.1. Historical market size by region, 2014-2016
    • 6.8.2. Market forecast by region, 2017-2025

7. Global regenerative medicines market by geography

  • 7.1. North America
    • 7.1.1. U.S.
      • 7.1.1.1. Historical market size, 2014-2016
      • 7.1.1.2. Market forecast, 2017-2025
    • 7.1.2. Canada
      • 7.1.2.1. Historical market size, 2014-2016
      • 7.1.2.2. Market forecast, 2017-2025
    • 7.1.3. Mexico
      • 7.1.3.1. Historical market size, 2014-2016
      • 7.1.3.2. Market forecast, 2017-2025
  • 7.2. Europe
    • 7.2.1. UK
      • 7.2.1.1. Historical market size, 2014-2016
      • 7.2.1.2. Market forecast, 2017-2025
    • 7.2.2. Germany
      • 7.2.2.1. Historical market size, 2014-2016
      • 7.2.2.2. Market forecast, 2017-2025
    • 7.2.3. France
      • 7.2.3.1. Historical market size, 2014-2016
      • 7.2.3.2. Market forecast, 2017-2025
    • 7.2.4. Spain
      • 7.2.4.1. Historical market size, 2014-2016
      • 7.2.4.2. Market forecast, 2017-2025
    • 7.2.5. Italy
      • 7.2.5.1. Historical market size, 2014-2016
      • 7.2.5.2. Market forecast, 2017-2025
    • 7.2.6. Rest of Europe
      • 7.2.6.1. Historical market size, 2014-2016
      • 7.2.6.2. Market forecast, 2017-2025
  • 7.3. Asia-Pacific
    • 7.3.1. China
      • 7.3.1.1. Historical market size, 2014-2016
      • 7.3.1.2. Market forecast, 2017-2025
    • 7.3.2. Japan
      • 7.3.2.1. Historical market size, 2014-2016
      • 7.3.2.2. Market forecast, 2017-2025
    • 7.3.3. India
      • 7.3.3.1. Historical market size, 2014-2016
      • 7.3.3.2. Market forecast, 2017-2025
    • 7.3.4. Australia
      • 7.3.4.1. Historical market size, 2014-2016
      • 7.3.4.2. Market forecast, 2017-2025
    • 7.3.5. South Korea
      • 7.3.5.1. Historical market size, 2014-2016
      • 7.3.5.2. Market forecast, 2017-2025
    • 7.3.6. Rest of Asia-Pacific
      • 7.3.6.1. Historical market size, 2014-2016
      • 7.3.6.2. Market forecast, 2017-2025
  • 7.4. LAMEA
    • 7.4.1. Brazil
      • 7.4.1.1. Historical market size, 2014-2016
      • 7.4.1.2. Market forecast, 2017-2025
    • 7.4.2. Saudi Arabia
      • 7.4.2.1. Historical market size, 2014-2016
      • 7.4.2.2. Market forecast, 2017-2025
    • 7.4.3. South Africa
      • 7.4.3.1. Historical market size, 2014-2016
      • 7.4.3.2. Market forecast, 2017-2025
    • 7.4.4. Rest of LAMEA
      • 7.4.4.1. Historical market size, 2014-2016
      • 7.4.4.2. Market forecast, 2017-2025

8. Company profiles

  • 8.1. Zimmer biomet holdings, inc.
    • 8.1.1. Overview
    • 8.1.2. Financials and business segments
    • 8.1.3. Recent developments
  • 8.2. Medtronic plc
    • 8.2.1. Overview
    • 8.2.2. Financials and business segments
    • 8.2.3. Recent developments
  • 8.3. Stryker corporation
    • 8.3.1. Overview
    • 8.3.2. Financials and business segments
    • 8.3.3. Recent developments
  • 8.4. Ocata therapeutics, inc.
    • 8.4.1. Overview
    • 8.4.2. Financials and business segments
    • 8.4.3. Recent developments
  • 8.5. Baxter international, inc.
    • 8.5.1. overview
    • 8.5.2. Financials and business segments
    • 8.5.3. Recent developments
  • 8.6. Depuy synthes
    • 8.6.1. Overview
    • 8.6.2. Financials and business segments
    • 8.6.3. Recent developments
  • 8.7. Organogenesis, inc.
    • 8.7.1. Overview
    • 8.7.2. Financials and business segments
    • 8.7.3. Recent developments
  • 8.8. Integra lifesciences holdings corporation
    • 8.8.1. Overview
    • 8.8.2. Financials and business segments
    • 8.8.3. Recent developments
  • 8.9. Acelity holdings, inc.
    • 8.9.1. overview
    • 8.9.2. Financials and business segments
    • 8.9.3. Recent developments
  • 8.10. Cryolife, inc.
    • 8.10.1. Overview
    • 8.10.2. Financials and business segments
    • 8.10.3. Recent developments

List of Tables

  • Table 1. Regenerative Medicines Market Share, by Type, 2014-2025
  • Table 2. Regenerative Medicines Market Share, by Material, 2014-2025
  • Table 3. Regenerative Medicines Market Share, by Application, 2014-2025
  • Table 4. Regenerative Medicines Market Share, by Region, 2014-2025
  • Table 5. Regenerative Medicines Market Value for Tissue Engineering , by Region, 2017-2025, $million
  • Table 6. Regenerative Medicines Market Value for Cell Therapy, by Region, 2017-2025, $million
  • Table 7. Regenerative Medicines Market Value for Small Molecules & Biologics, by Region, 2017-2025, $million
  • Table 8. Regenerative Medicines Market Value for Gene Therapy, by Region, 2017-2025, $million
  • Table 9. Regenerative Medicines Market Value for Synthetic Materials, by Type, 2014-2025, $million
  • Table 10. Regenerative Medicines Market Value for Synthetic Materials, by Region, 2017-2025, $million
  • Table 11. Regenerative Medicines Market Value for Biodegradable Synthetic Polymers, by Region, 2017-2025, $million
  • Table 12. Regenerative Medicines Market Value for Hydrogel Material, by Region, 2017-2025, $million
  • Table 13. Regenerative Medicines Market Value for Scaffold, by Region, 2017-2025, $million
  • Table 14. Regenerative Medicines Market Value for Artificial Vascular Graft Materials, by Region, 2017-2025, $million
  • Table 15. Regenerative Medicines Market Value for Genetically Engineered Materials, by Type, 2014-2025, $million
  • Table 16. Regenerative Medicines Market Value for Genetically Engineered Materials, by Region, 2017-2025, $million
  • Table 17. Regenerative Medicines Market Value for Deoxyribonucleic Acid Transfection Vectors, by Region, 2017-2025, $million
  • Table 18. Regenerative Medicines Market Value for Genetically Manipulated Cells, by Region, 2017-2025, $million
  • Table 19. Regenerative Medicines Market Value for Three-Dimensional Polymer Technology, by Region, 2017-2025, $million
  • Table 20. Regenerative Medicines Market Value for Transgenic, by Region, 2017-2025, $million
  • Table 21. Regenerative Medicines Market Value for Fibroblasts, by Region, 2017-2025, $million
  • Table 22. Regenerative Medicines Market Value for Neural Stem Cells, by Region, 2017-2025, $million
  • Table 23. Regenerative Medicines Market Value for Gene-Activated Matrices, by Region, 2017-2025, $million
  • Table 24. Regenerative Medicines Market Value for Pharmaceuticals, by Type, 2014-2025, $million
  • Table 25. Regenerative Medicines Market Value for Pharmaceuticals, by Region, 2017-2025, $million
  • Table 26. Regenerative Medicines Market Value for Small Molecules, by Region, 2017-2025, $million
  • Table 27. Regenerative Medicines Market Value for Biologics, by Region, 2017-2025, $million
  • Table 28. Regenerative Medicines Market Value for Biologically Derived Materials, by Type, 2017-2025, $million
  • Table 29. Regenerative Medicines Market Value for Biologically Derived Materials, by Region, 2017-2025, $million
  • Table 30. Regenerative Medicines Market Value for Collagen, by Region, 2017-2025, $million
  • Table 31. Regenerative Medicines Market Value for Xenogeneic Material, by Region, 2017-2025, $million
  • Table 32. Regenerative Medicines Market Value for Cardiovascular, by Region, 2017-2025, $million
  • Table 33. Regenerative Medicines Market Value for Ophthalmology, by Region, 2017-2025, $million
  • Table 34. Regenerative Medicines Market Value for Dermatology, by Region, 2017-2025, $million
  • Table 35. Regenerative Medicines Market Value for Musculoskeletal, by Region, 2017-2025, $million
  • Table 36. Regenerative Medicines Market Value for Wound Healing, by Region, 2017-2025, $million
  • Table 37. Regenerative Medicines Market Value for Oncology, by Region, 2017-2025, $million
  • Table 38. Regenerative Medicines Market Value for Neurology, by Region, 2017-2025, $million
  • Table 39. Regenerative Medicines Market Value for Others Application, by Region, 2017-2025, $million
  • Table 40. Regenerative Medicines Market Value for North America, by Country, 2017-2025, $million
  • Table 41. Regenerative Medicines Market Value for North America, by Type, 2014-2025, $million
  • Table 42. Regenerative Medicines Market Value for North America, by Material, 2014-2025, $million
  • Table 43. Regenerative Medicines Market Value for North America, by Application, 2014-2025, $million
  • Table 44. Regenerative Medicines Market Value for Europe, by Country, 2014-2025, $million
  • Table 45. Regenerative Medicines Market Value for Europe, by Type, 2014-2025, $million
  • Table 46. Regenerative Medicines Market Value for Europe, by Material, 2014-2025, $million
  • Table 47. Regenerative Medicines Market Value for Europe, by Application, 2014-2025, $million
  • Table 48. Regenerative Medicines Market Value for Asia-Pacific, by Country, 2014-2025, $million
  • Table 49. Regenerative Medicines Market Value for Asia-Pacific, by Type, 2014-2025, $million
  • Table 50. Regenerative Medicines Market Value for Asia-Pacific, by Material, 2014-2025, $million
  • Table 51. Regenerative Medicines Market Value for Asia-Pacific, by Application, 2014-2025, $million
  • Table 52. Regenerative Medicines Market Value for LAMEA, by Country, 2014-2025, $million
  • Table 53. Regenerative Medicines Market Value for LAMEA, by Type, 2014-2025, $million
  • Table 54. Regenerative Medicines Market Value for LAMEA, by Material, 2014-2025, $million
  • Table 55. Regenerative Medicines Market Value for LAMEA, by Application, 2014-2025, $million
  • Table 56. Zimmer Biomet Holdings, Inc. - Company Snapshot
  • Table 57. Medtronic plc - Company Snapshot
  • Table 58. Stryker Corporation - Company Snapshot
  • Table 59. Ocata Therapeutics, Inc. - Company Snapshot
  • Table 60. Baxter International, Inc. - Company Snapshot
  • Table 61. DePuy Synthes - Company Snapshot
  • Table 62. Organogenesis, Inc., - Company Snapshot
  • Table 63. Integra Lifesciences Holdings Corporation - Company Snapshot
  • Table 64. Acelity Holdings, Inc. - Company Snapshot
  • Table 65. CryoLife, Inc. - Company Snapshot

List of Figures

  • Figure 1. Regenerative Medicines Tissue Engineering Market Value, 2014-2016, $million
  • Figure 2. Regenerative Medicines Cell Therapy Market Value, 2014-2016, $million
  • Figure 3. Regenerative Medicines Small Molecules & Biologics Market Value, 2014-2016, $million
  • Figure 4. Regenerative Medicines Gene Therapy Market Value, 2014-2016, $million
  • Figure 5. Regenerative Medicines Synthetic Materials Market Value, 2014-2016, $million
  • Figure 6. Regenerative Medicines Biodegradable Synthetic Polymers Market Value, 2014-2016, $million
  • Figure 7. Regenerative Medicines Hydrogel Material Market Value, 2014-2016, $million
  • Figure 8. Regenerative Medicines Scaffold Market Value, 2014-2016, $million
  • Figure 9. Regenerative Medicines Artificial Vascular Graft Materials Market Value, 2014-2016, $million
  • Figure 10. Regenerative Medicines Genetically Engineered Materials Market Value, 2014-2016, $million
  • Figure 11. Regenerative Medicines Deoxyribonucleic Acid Transfection Vectors Market Value, 2014-2016, $million
  • Figure 12. Regenerative Medicines Genetically Manipulated Cells Market Value, 2014-2016, $million
  • Figure 13. Regenerative Medicines Three-Dimensional Polymer Technology Market Value, 2014-2016, $million
  • Figure 14. Regenerative Medicines Transgenic Market Value, 2014-2016, $million
  • Figure 15. Regenerative Medicines Fibroblasts Market Value, 2014-2016, $million
  • Figure 16. Regenerative Medicines Neural Stem Cells Market Value, 2014-2016, $million
  • Figure 17. Regenerative Medicines Gene-Activated Matrices Market Value, 2014-2016, $million
  • Figure 18. Regenerative Medicines Pharmaceuticals Market Value, 2014-2016, $million
  • Figure 19. Regenerative Medicines Small Molecules Market Value, 2014-2016, $million
  • Figure 20.Regenerative Medicines Biologics Market Value, 2014-2016, $million
  • Figure 21.Regenerative Medicines Biologically Derived Materials Market Value, 2014-2016, $million
  • Figure 22. Regenerative Medicines Collagen Market Value, 2014-2016, $million
  • Figure 23. Regenerative Medicines Xenogeneic Material Market Value, 2014-2016, $million
  • Figure 24. Regenerative Medicines Cardiovascular Market Value, 2014-2016, $million
  • Figure 25. Regenerative Medicines Ophthalmology Market Value, 2014-2016, $million
  • Figure 26. Regenerative Medicines Dermatology Market Value, 2014-2016, $million
  • Figure 27. Regenerative Medicines Musculoskeletal Market Value, 2014-2016, $million
  • Figure 28. Regenerative Medicines Wound Healing Market Value, 2014-2016, $million
  • Figure 29. Regenerative Medicines Oncology Market Value, 2014-2016, $million
  • Figure 30. Regenerative Medicines Neurology Market Value, 2014-2016, $million
  • Figure 31. Regenerative Medicines Other Applications Market Value, 2014-2016, $million
  • Figure 32. Regenerative Medicines: U.S. Market Value, 2014-2016, $million
  • Figure 33. Regenerative Medicines: U.S. Market Value, 2017-2025, $million
  • Figure 34. Regenerative Medicines: Canada Market Value, 2014-2016, $million
  • Figure 35. Regenerative Medicines: Canada Market Value, 2017-2025, $million
  • Figure 36. Regenerative Medicines: Mexico Market Value, 2014-2016, $million
  • Figure 37. Regenerative Medicines: Mexico Market Value, 2017-2025, $million
  • Figure 38. Regenerative Medicines: UK Market Value, 2014-2016, $million
  • Figure 39.Regenerative Medicines: UKMarket Value, 2017-2025, $million
  • Figure 40. Regenerative Medicines: Germany Market Value, 2014-2016, $million
  • Figure 41. Regenerative Medicines: Germany Market Value, 2017-2025, $million
  • Figure 42. Regenerative Medicines: France Market Value, 2014-2016, $million
  • Figure 43. Regenerative Medicines: France Market Value, 2017-2025, $million
  • Figure 44. Regenerative Medicines: Spain Market Value, 2014-2016, $million
  • Figure 45. Regenerative Medicines: Spain Market Value, 2017-2025, $million
  • Figure 46. Regenerative Medicines: Italy Market Value, 2014-2016, $million
  • Figure 47. Regenerative Medicines: Italy Market Value, 2017-2025, $million
  • Figure 48. Regenerative Medicines: Rest of Europe Market Value, 2014-2016, $million
  • Figure 49. Regenerative Medicines: Rest of Europe Market Value, 2017-2025, $million
  • Figure 50. Regenerative Medicines: China Market Value, 2014-2016, $million
  • Figure 51. Regenerative Medicines: China Market Value, 2017-2025, $million
  • Figure 52. Regenerative Medicines: Japan Market Value, 2014-2016, $million
  • Figure 53. Regenerative Medicines: Japan Market Value, 2017-2025, $million
  • Figure 54. Regenerative Medicines: India Market Value, 2014-2016, $million
  • Figure 55. Regenerative Medicines: India Market Value, 2017-2025, $million
  • Figure 56. Regenerative Medicines: Australia Market Value, 2014-2016, $million
  • Figure 57. Regenerative Medicines: Australia Market Value, 2017-2025, $million
  • Figure 58. Regenerative Medicines: South Korea Market Value, 2014-2016, $million
  • Figure 59. Regenerative Medicines: South Korea Market Value, 2017-2025, $million
  • Figure 60. Regenerative Medicines: Rest of Asia-Pacific Market Value, 2014-2016, $million
  • Figure 61. Regenerative Medicines: Rest of Asia-Pacific Market Value, 2017-2025, $million
  • Figure 62. Regenerative Medicines: Brazil Market Value, 2014-2016, $million
  • Figure 63. Regenerative Medicines: Brazil Market Value, 2017-2025, $million
  • Figure 64. Regenerative Medicines: Saudi Arabia Market Value, 2014-2016, $million
  • Figure 65. Regenerative Medicines: Saudi Arabia Market Value, 2017-2025, $million
  • Figure 66. Regenerative Medicines: South Africa Market Value, 2014-2016, $million
  • Figure 67. Regenerative Medicines: South Africa Market Value, 2017-2025, $million
  • Figure 68. Regenerative Medicines: Rest of LAMEA Market Value, 2014-2016, $million
  • Figure 69. Regenerative Medicines: Rest of LAME Market Value, 2017-2025, $million
Back to Top